Clinical trial
Progesterone Treatment of Blunt Traumatic Brain Injury
NCT00048646 · David Wright, Other · Completed
Key facts
| NCT number | NCT00048646 |
|---|---|
| Title | Progesterone Treatment of Blunt Traumatic Brain Injury |
| Official title | ProTECT: Single Center, Phase II (Pilot), Double Blind, 4:1 Randomized, Placebo Controlled Clinical Trial for Progesterone Treatment of Moderate and Severe Blunt TBI |
| Lead sponsor | David Wright, Other |
| Collaborators | National Institute of Neurological Disorders and Stroke (NINDS) NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Traumatic Brain Injury |
| Intervention type | Drug |
| Interventions | IV Progesterone |
| Enrollment | 100 |
| Start date | May 1, 2002 |
| Primary completion | Sep 1, 2005 |
| Completion | Sep 1, 2005 |
| First posted | Nov 6, 2002 |
| Last update posted | Sep 19, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: